Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03219515Unknown
Randomised, double-blind trial in psychogenic dizziness (PPPD) comparing Gongjin-dan with Placebo (2 arms). Primary endpoint: Dizziness Handicap Inventory at 56 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03219515.